Saturday, October 3, 2026

USD/EUR Bearish Momentum: 0.786% Down In The Last 24 Hours

ViaNews Editorial Team

November 3, 2023

USD/EUR Bearish Momentum: 0.786% Down In The Last 24 Hours

(VIANEWS) - USD/EUR (USDEUR) has been up by 0.7864% for the last session's close. At 18:10 EST on Friday, 3 November, USD/EUR (USDEUR) is $0.93.

USD/EUR (USDEUR) Range

Concerning USD/EUR's daily highs and lows, it's 0.384% down from its trailing 24 hours low of $0.94 and 1.185% down from its trailing 24 hours high of $0.94.

USD/EUR's yearly highs and lows, it's 5.266% up from its 52-week low and 8.988% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.06%, a negative 0.05%, and a positive 0.28%, respectively.

USD/EUR's highest amplitude of average volatility was 0.23% (last week), 0.28% (last month), and 0.28% (last quarter), respectively.

News about

  • According to FXStreet on Wednesday, 1 November, "In any case, the 50-day Simple Moving Average (SMA) aligns as initial resistance at 1.0650 for EUR/USD before 1.0750 (Fibonacci 38.2% retracement level of the July-October downtrend) and 1.0800 (100-day SMA, 200-day SMA). "
  • Eur/usd price analysis: hovers above the 1.0550 key level ahead of fed decision. According to FXStreet on Wednesday, 1 November, "A successful breach above the mentioned resistance levels could potentially invigorate the EUR/USD pair to revisit October's high at the 1.0694 level.", "The EUR/USD pair could find support around the psychological level of 1.0550, followed by the previous week's low at 1.0521. "
  • Eur/usd forecast: November 2023 - 01 November 2023. According to DailyForex on Wednesday, 1 November, "Yesterday's move lower in the EUR/USD perhaps not coincidentally occurred when European GDP numbers proved to be recessionary, and U.", "If the EUR/USD sustains value below the 1.06000 level this could continue to make short-term traders nervous and consider the potential that the 1.05500 support ratio below could be a target.EUR/USD Outlook for November 2023:"
  • Eur/usd stays near 1.0550 as fed keeps rates unchaged. According to FXStreet on Wednesday, 1 November, "The EUR/USD rose modestly to 1.0552 after the FOMC statement and then lost momentum. "
  • Eur/usd drops to fresh weekly lows, despite mixed US economic data. According to FXStreet on Wednesday, 1 November, "The EUR/USD downtrend remains intact, and it could accelerate if the pair achieves a daily close below the bottom trendline of the bearish flag. "

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com